\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ is\\ remarkable\\ for\\ fine\\ crackles\\ over\\ the\\ left\\ lower\\ posterior\\ hemithorax\\.\ \(0\)\
\-\ this\\ patient\\‚\\Ä\\ôs\\ radiograph\\ returned\\ to\\ normal\\ and\\ his\\ symptoms\\ resolved\\ after\\ two\\ months\\ of\\ treatment\\ with\\ oral\\ corticosteroids\\.\ \(0\)\
\-\ \\‚\\Ä\\úgarland\\‚\\Ä\\ôs\\ triad\\‚\\Ä\\ù\\ \\(\\‚\\Ä\\ú1\\-2\\-3\\‚\\Ä\\ù\\ sign\\)\\ of\\ thoracic\\ lymphadenopathy\\:\\ there\\ are\\ bilateral\\ hilar\\ and\\ right\\ paratracheal\\ opacities\\,\\ the\\ lobulated\\ contours\\ being\\ typical\\ of\\ lymph\\ node\\ enlargement\\.\ \(0\)\
\-\ note\\ also\\ the\\ lymphadenopathy\\ at\\ the\\ aorticopulmonary\\ window\\ region\\.\ \(0\)\
\-\ also\\ noted\\ is\\ a\\ reticulonodular\\ interstitial\\ pattern\\ at\\ the\\ lung\\ bases\\,\\ left\\ greater\\ than\\ right\\.\ \(0\)\
\-\ incidental\\ findings\\ include\\ degenerative\\ changes\\ of\\ the\\ right\\ shoulder\\ joint\\,\\ with\\ calcification\\ of\\ the\\ coracoclavicular\\ ligament\\.\ \(0\)\
\-\ stage\\ ii\\ sarcoidosis\\ manifiesting\\ with\\ garland\\‚\\Ä\\ôs\\ triad\\,\\ aorticopulmonary\\ window\\ lymphadenopathy\\ and\\ parenchymal\\ disease\\ at\\ the\\ lung\\ bases\\.\ \(0\)\
\-\ differential\\ diagnostic\\ considerations\\ for\\ bilateral\\ hilar\\ opacities\\ include\\ two\\ major\\ categories\\ of\\ pathology\\:\\ \\(bilaterally\\)\\ enlarged\\ pulmonary\\ arteries\\ \\(pulmonary\\ arterial\\ hypertension\\ \\[pah\\]\\)\\ and\\ bilateral\\ hilar\\ lymphadenopathy\\.\\ \ \(0\)\
\-\ pulmonary\\ arterial\\ hypertension\\ may\\ be\\ divided\\ into\\ \\(1\\)\\ cardiac\\ causes\\ including\\ left\\-sided\\ heart\\ failure\\,\\ mitral\\ stenosis\\,\\ left\\ atrial\\ myxoma\\,\\ and\\ cardiac\\ shunts\\ \\(vsd\\,\\ asd\\,\\ pda\\,\\ truncus\\ arteriosis\\,\\ and\\ transposition\\ of\\ the\\ great\\ vessels\\)\\ and\\ \\(2\\)\\ pulmonary\\ causes\\ including\\ emphysema\\;\\ chronic\\ interstitial\\ lung\\ disease\\,\\ acute\\ and\\ chronic\\ pulmonary\\ emboli\\;\\ portal\\ hypertension\\;\\ metastatic\\ tumor\\ emboli\\;\\ and\\ idiopathic\\ \\(primary\\)\\ pulmonary\\ hypertension\\ \\(plexogenic\\ pulmonary\\ arteriopathy\\)\\.\\ \ \(0\)\
\-\ the\\ three\\ major\\ etiologies\\ of\\ bilateral\\ hilar\\ adenopathy\\ are\\:\\ \ \(0\)\
\-\ \\(1\\)\\ neoplasms\\ including\\ lymphoma\\,\\ leukemia\\ \\(cll\\)\\,\\ metastases\\ \\(e\\.g\\.\\,\\ renal\\ cell\\ carcinoma\\)\\ and\\,\\ rarely\\,\\ primary\\ bronchogenic\\ carcinoma\\ \\(usually\\ unilateral\\ or\\ asymmetric\\)\\;\\ \ \(0\)\
\-\ \\(2\\)\\ inflammation\\ including\\ sarcoidosis\\ or\\ occupation\\ lung\\ diseases\\ like\\ silicosis\\,\\ and\\ \ \(1\)\
\-\ \\(3\\)\\ collagen\\-vascular\\ diseases\\ including\\ lupus\\ \\(rarely\\)\\,\\ polyarteritis\\ nodosa\\,\\ and\\ mixed\\ connective\\ tissues\\ diseases\\.\\ neoplastic\\ and\\ inflammatory\\ diseases\\ that\\ more\\ commonly\\ present\\ as\\ unilateral\\ hilar\\ adenopathy\\ include\\,\\ in\\ the\\ neoplastic\\ category\\,\\ bronchogenic\\ carcinoma\\,\\ metastases\\,\\ and\\ lymphoma\\ and\\,\\ in\\ the\\ inflammatory\\ category\\,\\ tuberculosis\\,\\ fungal\\ infections\\ \\(including\\ histoplasmosis\\,\\ coccidioidomycosis\\,\\ and\\ blastomycosis\\)\\,\\ viral\\ infections\\ \\(including\\ atypical\\ measles\\)\\,\\ infectious\\ mononucleosis\\,\\ aids\\,\\ drug\\ reactions\\ \\(e\\.g\\.\\,\\ phenytoin\\/dilantin\\)\\,\\ and\\ bilateral\\ lung\\ abscesses\\.\ \(0\)\
\-\ a\\ 41\\ year\\-old\\ black\\ male\\ nonsmoker\\ with\\ a\\ 1\\-year\\ history\\ of\\ progressive\\ dyspnea\\ on\\ exertion\\,\\ cough\\,\\ chest\\ discomfort\\,\\ weight\\ loss\\,\\ and\\ anorexia\\.\ \(0\)\
\-\ the\\ radiographic\\ manifestations\\ of\\ sarcoidosis\\ are\\ classified\\ into\\ three\\ major\\ stages\\ as\\ follows\\:\\ \ \(0\)\
\-\ stage\\ i\\:\\ hilar\\ or\\ mediastinal\\ adenopathy\\ \\(or\\ both\\)\\ without\\ associated\\ parenchymal\\ disease\\ \ \(0\)\
\-\ stage\\ ii\\:\\ concomitant\\ lymphadenopathy\\ and\\ parenchymal\\ disease\\ \ \(0\)\
\-\ stage\\ iii\\:\\ diffuse\\ parenchymal\\ disease\\ without\\ associated\\ lymphadenopathy\\ \ \(0\)\
\-\ other\\ stages\\ sometimes\\ mentioned\\ include\\ stage\\ 0\\ \\(normal\\ chest\\ radiograph\\)\\ and\\ stage\\ iv\\ \\(pulmonary\\ fibrosis\\)\\.\\ \ \(0\)\
\-\ the\\ staging\\ system\\ is\\ important\\ for\\ two\\ main\\ reasons\\:\\ it\\ is\\ a\\ means\\ of\\ describing\\ the\\ radiographic\\ findings\\ \\(although\\ patients\\ do\\ not\\ necessarily\\ progress\\ sequentially\\ from\\ one\\ stage\\ to\\ the\\ next\\)\\ and\\ it\\ has\\ been\\ shown\\ to\\ correlate\\ with\\ clinical\\ outcome\\.\\ in\\ a\\ survey\\ of\\ 3\\,676\\ patients\\ with\\ sarcoidosis\\ from\\ nine\\ countries\\,\\ 8\\%\\ had\\ stage\\ 0\\ disease\\,\\ 51\\%\\ had\\ stage\\ i\\ disease\\,\\ 29\\%\\ had\\ stage\\ ii\\ disease\\,\\ and\\ 12\\%\\ had\\ stage\\ iii\\ disease\\ and\\,\\ on\\ follow\\-up\\,\\ 65\\%\\ of\\ patients\\ with\\ stage\\ i\\ disease\\ showed\\ resolution\\ of\\ radiographic\\ findings\\ versus\\ 49\\%\\ of\\ those\\ with\\ stage\\ ii\\ disease\\ and\\ 20\\%\\ of\\ those\\ with\\ stage\\ iii\\ disease\\.\\ sites\\ of\\ lymph\\ node\\ enlargement\\ in\\ decreasing\\ order\\ of\\ frequency\\ include\\ the\\ hilar\\,\\ the\\ right\\ paratracheal\\ region\\,\\ the\\ aortopulmonary\\ window\\,\\ the\\ subcarinal\\ space\\,\\ the\\ anterior\\ mediastinum\\,\\ and\\ the\\ posterior\\ mediastinum\\.\\ the\\ \\‚\\Ä\\ú1\\-2\\-3\\‚\\Ä\\ù\\ sign\\ is\\ a\\ common\\ radiographic\\ finding\\ in\\ sarcoidosis\\ and\\ denotes\\ the\\ combination\\ of\\ bilateral\\ hilar\\ and\\ right\\ paratracheal\\ lymph\\ enlargement\\.\\ the\\ parenchymal\\ abnormalities\\ in\\ sarcoidosis\\ are\\ usually\\ bilateral\\ and\\ symmetrical\\ and\\ may\\ have\\ an\\ upper\\ lung\\ zone\\ predominance\\;\\ the\\ most\\ frequent\\ patterns\\ are\\ the\\ nodular\\ pattern\\ and\\ the\\ reticulonodular\\ pattern\\;\\,\\ less\\ frequently\\,\\ a\\ reticular\\ pattern\\,\\ air\\-space\\ consolidation\\,\\ or\\ ground\\-glass\\ opacities\\ are\\ the\\ dominant\\ roentgenographic\\ finding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.06971377323087001\ \(0\)\
\-\ hilar\\:\\ 0\\.0469260092559285\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.03163681447840359\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.029784712079298472\ \(0\)\
\-\ including\\:\\ 0\\.029505369517691896\ \(0\)\
\-\ parenchymal\\:\\ 0\\.02869124253500846\ \(0\)\
\-\ pulmonary\\:\\ 0\\.02728470284393512\ \(0\)\
\-\ diseases\\:\\ 0\\.02352272632486147\ \(0\)\
\-\ disease\\:\\ 0\\.022897336741241052\ \(0\)\
\-\ garland\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ 1\\-2\\-3\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ aorticopulmonary\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ paratracheal\\:\\ 0\\.021925338201503164\ \(0\)\
\-\ \\(\\:\\ 0\\.021710325105689796\ \(0\)\
\-\ \\)\\:\\ 0\\.021445121894115727\ \(0\)\
\-\ lung\\:\\ 0\\.020288189510153657\ \(0\)\
\-\ window\\:\\ 0\\.02026359595515823\ \(0\)\
\-\ ii\\:\\ 0\\.02013999841007336\ \(0\)\
\-\ \\,\\:\\ 0\\.019970414669308083\ \(0\)\
\-\ bilateral\\:\\ 0\\.019831590307651786\ \(0\)\
\-\ \\;\\:\\ 0\\.019368781856787098\ \(0\)\
\-\ \\%\\:\\ 0\\.019061813160412642\ \(0\)\
\-\ hypertension\\:\\ 0\\.018408639630055672\ \(0\)\
\-\ opacities\\:\\ 0\\.018273809824905354\ \(0\)\
\-\ pattern\\:\\ 0\\.017849411688914088\ \(0\)\
\-\ radiographic\\:\\ 0\\.01772330268737013\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.016687071647170187\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.01651073688996371\ \(0\)\
\-\ iii\\:\\ 0\\.016440563029644435\ \(0\)\
\-\ include\\:\\ 0\\.016373999235179553\ \(0\)\
\-\ major\\:\\ 0\\.016373921550661728\ \(0\)\
\-\ triad\\:\\ 0\\.015767748596292555\ \(0\)\
\-\ adenopathy\\:\\ 0\\.015593783319140339\ \(0\)\
\-\ category\\:\\ 0\\.015291373221580046\ \(0\)\
\-\ i\\:\\ 0\\.014476699570608648\ \(0\)\
\-\ lymph\\:\\ 0\\.014137468889117405\ \(0\)\
\-\ stages\\:\\ 0\\.01400721030014361\ \(0\)\
\-\ 0\\:\\ 0\\.01400721030014361\ \(0\)\
\-\ enlargement\\:\\ 0\\.013895772157725802\ \(0\)\
\-\ bases\\:\\ 0\\.01334342292689118\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.013079921794176885\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.013006603905854036\ \(0\)\
\-\ emboli\\:\\ 0\\.012638971808579433\ \(0\)\
\-\ \\:\\:\\ 0\\.012352730229406176\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.012326375220662098\ \(0\)\
\-\ manifiesting\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ plexogenic\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ phenytoin\\/dilantin\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ sequentially\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ 3\\,676\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ neoplastic\\:\\ 0\\.011947724501301042\ \(0\)\
\-\ unilateral\\:\\ 0\\.011586905588697037\ \(0\)\
\-\ interstitial\\:\\ 0\\.011422921955565197\ \(0\)\
\-\ mediastinum\\:\\ 0\\.011243273382989295\ \(0\)\
\-\ rarely\\:\\ 0\\.011194042493637714\ \(0\)\
\-\ infections\\:\\ 0\\.011098164570656103\ \(0\)\
\-\ cll\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ collagen\\-vascular\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ 1\\-year\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ roentgenographic\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ node\\:\\ 0\\.010683725807453739\ \(0\)\
\-\ those\\:\\ 0\\.010623674149752169\ \(0\)\
\-\ arteriosis\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ aortopulmonary\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ denotes\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.010467322703464984\ \(0\)\
\-\ arterial\\:\\ 0\\.01021952078888708\ \(0\)\
\-\ reactions\\:\\ 0\\.01014921320061012\ \(0\)\
\-\ countries\\:\\ 0\\.01014921320061012\ \(0\)\
\-\ had\\:\\ 0\\.010075682072353596\ \(0\)\
\-\ s\\:\\ 0\\.010044129783256505\ \(0\)\
\-\ two\\:\\ 0\\.010030046055803302\ \(0\)\
\-\ metastases\\:\\ 0\\.009974678825254055\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009925933073835519\ \(0\)\
\-\ coracoclavicular\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ pah\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ arteriopathy\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ nonsmoker\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ truncus\\:\\ 0\\.00959529911849514\ \(0\)\
\-\ describing\\:\\ 0\\.00959529911849514\ \(0\)\
\-\ are\\:\\ 0\\.009548146496144277\ \(0\)\
\-\ blastomycosis\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ measles\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ occupation\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ causes\\:\\ 0\\.009089018300026808\ \(0\)\
\-\ patients\\:\\ 0\\.009063830325270599\ \(0\)\
\-\ air\\-space\\:\\ 0\\.009041385036380162\ \(0\)\
\-\ coccidioidomycosis\\:\\ 0\\.008897449905700072\ \(0\)\
\-\ mononucleosis\\:\\ 0\\.008897449905700072\ \(0\)\
\-\ cardiac\\:\\ 0\\.008892996702051832\ \(0\)\
\-\ nodosa\\:\\ 0\\.008767244742032962\ \(0\)\
\-\ subcarinal\\:\\ 0\\.008648376740681007\ \(0\)\
\-\ transposition\\:\\ 0\\.008539028779378363\ \(0\)\
\-\ shunts\\:\\ 0\\.008437788380261256\ \(0\)\
\-\ necessarily\\:\\ 0\\.008343535823585093\ \(0\)\
\-\ ground\\-glass\\:\\ 0\\.008343535823585093\ \(0\)\
\-\ myxoma\\:\\ 0\\.008255368444981854\ \(0\)\
\-\ inflammatory\\:\\ 0\\.00809649165079788\ \(0\)\
\-\ contours\\:\\ 0\\.00809446265856603\ \(0\)\
\-\ silicosis\\:\\ 0\\.00809446265856603\ \(0\)\
\-\ anorexia\\:\\ 0\\.00809446265856603\ \(0\)\
\-\ sign\\:\\ 0\\.008088651644164129\ \(0\)\
\-\ nine\\:\\ 0\\.008020600334426309\ \(0\)\
\-\ categories\\:\\ 0\\.007950527527885939\ \(0\)\
\-\ pda\\:\\ 0\\.007950527527885939\ \(0\)\
\-\ vsd\\:\\ 0\\.007883874298146278\ \(0\)\
\-\ three\\:\\ 0\\.007870558000947842\ \(0\)\
\-\ classified\\:\\ 0\\.007645686610790023\ \(0\)\
\-\ concomitant\\:\\ 0\\.007592106401564229\ \(0\)\
\-\ reticular\\:\\ 0\\.007592106401564229\ \(0\)\
\-\ symmetrical\\:\\ 0\\.007540548576451051\ \(0\)\
\-\ finding\\:\\ 0\\.007524758210487654\ \(0\)\
\-\ findings\\:\\ 0\\.0074542497368440975\ \(0\)\
\-\ decreasing\\:\\ 0\\.007442927040956317\ \(0\)\
\-\ patterns\\:\\ 0\\.007442927040956317\ \(0\)\
\-\ radiograph\\:\\ 0\\.007437018180113012\ \(0\)\
\-\ asd\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ histoplasmosis\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ means\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ and\\:\\ 0\\.00737741826771387\ \(0\)\
\-\ divided\\:\\ 0\\.007351818605848842\ \(0\)\
\-\ aids\\:\\ 0\\.007308446067167721\ \(0\)\
\-\ predominance\\:\\ 0\\.007308446067167721\ \(0\)\
\-\ correlate\\:\\ 0\\.007266408282103849\ \(0\)\
\-\ survey\\:\\ 0\\.007186025085351208\ \(0\)\
\-\ mitral\\:\\ 0\\.0071475402807518965\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.007110109988145183\ \(0\)\
\-\ usually\\:\\ 0\\.007089967906739779\ \(0\)\
\-\ mentioned\\:\\ 0\\.006969872072762555\ \(0\)\
\-\ outcome\\:\\ 0\\.006969872072762555\ \(0\)\
\-\ reasons\\:\\ 0\\.006936951920332144\ \(0\)\
\-\ primary\\:\\ 0\\.006916350445070209\ \(0\)\
\-\ lupus\\:\\ 0\\.006873399986404695\ \(0\)\
\-\ connective\\:\\ 0\\.006873399986404695\ \(0\)\
\-\ exertion\\:\\ 0\\.006842699363655982\ \(0\)\
\-\ or\\:\\ 0\\.006841002383631882\ \(0\)\
\-\ crackles\\:\\ 0\\.006783293473027923\ \(0\)\
\-\ fine\\:\\ 0\\.0067263635599123925\ \(0\)\
\-\ considerations\\:\\ 0\\.0067263635599123925\ \(0\)\
\-\ black\\:\\ 0\\.0067263635599123925\ \(0\)\
\-\ staging\\:\\ 0\\.0067263635599123925\ \(0\)\
\-\ lymphoma\\:\\ 0\\.006672673864452147\ \(0\)\
\-\ manifestations\\:\\ 0\\.006645184023750096\ \(0\)\
\-\ region\\:\\ 0\\.006594538872238559\ \(0\)\
\-\ hemithorax\\:\\ 0\\.006593626198636918\ \(0\)\
\-\ abscesses\\:\\ 0\\.006593626198636918\ \(0\)\
\-\ progress\\:\\ 0\\.006593626198636918\ \(0\)\
\-\ chronic\\:\\ 0\\.006576474406849726\ \(0\)\
\-\ etiologies\\:\\ 0\\.006472651612104889\ \(0\)\
\-\ 49\\:\\ 0\\.006472651612104889\ \(0\)\
\-\ emphysema\\:\\ 0\\.006383037838217166\ \(0\)\
\-\ great\\:\\ 0\\.006361523689353587\ \(0\)\
\-\ sites\\:\\ 0\\.006361523689353587\ \(0\)\
\-\ remarkable\\:\\ 0\\.006340343106654181\ \(0\)\
\-\ 51\\:\\ 0\\.006340343106654181\ \(0\)\
\-\ follows\\:\\ 0\\.006278703167746437\ \(0\)\
\-\ 41\\:\\ 0\\.006219724790881397\ \(0\)\
\-\ zone\\:\\ 0\\.006200617902937764\ \(0\)\
\-\ frequency\\:\\ 0\\.006163187610331049\ \(0\)\
\-\ right\\:\\ 0\\.006158686537639458\ \(0\)\
\-\ portal\\:\\ 0\\.006144850150860913\ \(0\)\
\-\ \\]\\:\\ 0\\.006108897543869965\ \(0\)\
\-\ \\[\\:\\ 0\\.006091269941635119\ \(0\)\
\-\ 29\\:\\ 0\\.006091269941635119\ \(0\)\
\-\ leukemia\\:\\ 0\\.005990029542518011\ \(0\)\
\-\ drug\\:\\ 0\\.005990029542518011\ \(0\)\
\-\ returned\\:\\ 0\\.005973862250650521\ \(0\)\
\-\ atrial\\:\\ 0\\.005973862250650521\ \(0\)\
\-\ dominant\\:\\ 0\\.005957884054252719\ \(0\)\
\-\ neoplasms\\:\\ 0\\.005942090581027206\ \(0\)\
\-\ sometimes\\:\\ 0\\.005942090581027206\ \(0\)\
\-\ next\\:\\ 0\\.005926477608590562\ \(0\)\
\-\ viral\\:\\ 0\\.005880681581215367\ \(0\)\
\-\ combination\\:\\ 0\\.005880681581215367\ \(0\)\
\-\ lobulated\\:\\ 0\\.005865751156991062\ \(0\)\
\-\ discomfort\\:\\ 0\\.00585098214591973\ \(0\)\
\-\ order\\:\\ 0\\.00585098214591973\ \(0\)\
\-\ consolidation\\:\\ 0\\.00585098214591973\ \(0\)\
\-\ frequent\\:\\ 0\\.00583637109521379\ \(0\)\
\-\ left\\-sided\\:\\ 0\\.005751841855161757\ \(0\)\
\-\ 65\\:\\ 0\\.005698261645935964\ \(0\)\
\-\ asymmetric\\:\\ 0\\.00567223952165906\ \(0\)\
\-\ resolved\\:\\ 0\\.005659412007519934\ \(0\)\
\-\ fungal\\:\\ 0\\.005659412007519934\ \(0\)\
\-\ chest\\:\\ 0\\.005586691256987756\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.005560910239895148\ \(0\)\
\-\ into\\:\\ 0\\.005555536524480074\ \(0\)\
\-\ 1\\:\\ 0\\.005555536524480074\ \(0\)\
\-\ versus\\:\\ 0\\.0055490822853280514\ \(0\)\
\-\ dyspnea\\:\\ 0\\.005525729234290756\ \(0\)\
\-\ associated\\:\\ 0\\.005509460551660387\ \(0\)\
\-\ without\\:\\ 0\\.005497303733219017\ \(0\)\
\-\ the\\:\\ 0\\.005477089148094465\ \(0\)\
\-\ main\\:\\ 0\\.0054361154604030335\ \(0\)\
\-\ like\\:\\ 0\\.005403969972137741\ \(0\)\
\-\ posterior\\:\\ 0\\.005381526089350952\ \(0\)\
\-\ ligament\\:\\ 0\\.005362253136263312\ \(0\)\
\-\ idiopathic\\:\\ 0\\.0053217725384404006\ \(0\)\
\-\ degenerative\\:\\ 0\\.005292180329722943\ \(0\)\
\-\ it\\:\\ 0\\.00524821962987163\ \(0\)\
\-\ important\\:\\ 0\\.005244241368232136\ \(0\)\
\-\ fibrosis\\:\\ 0\\.005197927773046779\ \(0\)\
\-\ mixed\\:\\ 0\\.005126944523141436\ \(0\)\
\-\ may\\:\\ 0\\.005121115762016732\ \(0\)\
\-\ do\\:\\ 0\\.0050677226093796685\ \(0\)\
\-\ atypical\\:\\ 0\\.005059468081434365\ \(0\)\
\-\ frequently\\:\\ 0\\.005059468081434365\ \(0\)\
\-\ resolution\\:\\ 0\\.00503499960251834\ \(0\)\
\-\ 2\\:\\ 0\\.005027607913963241\ \(0\)\
\-\ infectious\\:\\ 0\\.005018927414568085\ \(0\)\
\-\ inflammation\\:\\ 0\\.004964118679883079\ \(0\)\
\-\ mediastinal\\:\\ 0\\.004956465325308392\ \(0\)\
\-\ oral\\:\\ 0\\.00491882877917693\ \(0\)\
\-\ nodular\\:\\ 0\\.004896734709169278\ \(0\)\
\-\ arteries\\:\\ 0\\.004832518804284127\ \(0\)\
\-\ tissues\\:\\ 0\\.004791326129187559\ \(0\)\
\-\ pathology\\:\\ 0\\.004777866707817325\ \(0\)\
\-\ 12\\:\\ 0\\.004777866707817325\ \(0\)\
\-\ at\\:\\ 0\\.004744930954228004\ \(0\)\
\-\ shoulder\\:\\ 0\\.0047061207593426715\ \(0\)\
\-\ vessels\\:\\ 0\\.0046997814430086516\ \(0\)\
\-\ typical\\:\\ 0\\.004680938106762292\ \(0\)\
\-\ shown\\:\\ 0\\.004680938106762292\ \(0\)\
\-\ diagnostic\\:\\ 0\\.00462591911886893\ \(0\)\
\-\ progressive\\:\\ 0\\.004613987862081015\ \(0\)\
\-\ also\\:\\ 0\\.004602785775055058\ \(0\)\
\-\ system\\:\\ 0\\.004596284112569396\ \(0\)\
\-\ failure\\:\\ 0\\.004573030441026457\ \(0\)\
\-\ stenosis\\:\\ 0\\.004573030441026457\ \(0\)\
\-\ note\\:\\ 0\\.004505553999319386\ \(0\)\
\-\ thoracic\\:\\ 0\\.00450007856025171\ \(0\)\
\-\ cough\\:\\ 0\\.00447302579072141\ \(0\)\
\-\ incidental\\:\\ 0\\.004420476226749011\ \(0\)\
\-\ commonly\\:\\ 0\\.004405097600349237\ \(0\)\
\-\ greater\\:\\ 0\\.0043848584121181705\ \(0\)\
\-\ 8\\:\\ 0\\.004364914697061951\ \(0\)\
\-\ year\\-old\\:\\ 0\\.004287929811063137\ \(0\)\
\-\ abnormalities\\:\\ 0\\.004287929811063137\ \(0\)\
\-\ iv\\:\\ 0\\.004260143357187287\ \(0\)\
\-\ calcification\\:\\ 0\\.0042374120470725805\ \(0\)\
\-\ 20\\:\\ 0\\.004197425186006853\ \(0\)\
\-\ weight\\:\\ 0\\.004184352165492985\ \(0\)\
\-\ being\\:\\ 0\\.004068016361749397\ \(0\)\
\-\ heart\\:\\ 0\\.004056119738946412\ \(0\)\
\-\ enlarged\\:\\ 0\\.0039830888939672215\ \(0\)\
\-\ less\\:\\ 0\\.003953469951260495\ \(0\)\
\-\ although\\:\\ 0\\.003942526339585524\ \(0\)\
\-\ left\\:\\ 0\\.0039184642183316175\ \(0\)\
\-\ space\\:\\ 0\\.0038614166763342003\ \(0\)\
\-\ is\\:\\ 0\\.0038407840053601475\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0038342967739397587\ \(0\)\
\-\ showed\\:\\ 0\\.003827600092791935\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.0037978647424067513\ \(0\)\
\-\ a\\:\\ 0\\.003792621055642362\ \(0\)\
\-\ joint\\:\\ 0\\.0037751765779263403\ \(0\)\
\-\ differential\\:\\ 0\\.003706229275072308\ \(0\)\
\-\ normal\\:\\ 0\\.003660143318576779\ \(0\)\
\-\ clinical\\:\\ 0\\.0035919532787786943\ \(0\)\
\-\ diffuse\\:\\ 0\\.003534163142589228\ \(0\)\
\-\ as\\:\\ 0\\.0035316325297653764\ \(0\)\
\-\ renal\\:\\ 0\\.003507480258822499\ \(0\)\
\-\ from\\:\\ 0\\.0034602068665415637\ \(0\)\
\-\ in\\:\\ 0\\.003454075656887336\ \(0\)\
\-\ loss\\:\\ 0\\.003388612257470546\ \(0\)\
\-\ his\\:\\ 0\\.003364602496785426\ \(0\)\
\-\ changes\\:\\ 0\\.003345693956605274\ \(0\)\
\-\ months\\:\\ 0\\.0031884443916530975\ \(0\)\
\-\ been\\:\\ 0\\.003175949302546436\ \(0\)\
\-\ one\\:\\ 0\\.003163567463539131\ \(0\)\
\-\ cell\\:\\ 0\\.003153334305439189\ \(0\)\
\-\ than\\:\\ 0\\.003058809911090538\ \(0\)\
\-\ common\\:\\ 0\\.0030550098523994497\ \(0\)\
\-\ of\\:\\ 0\\.0030240057584177324\ \(0\)\
\-\ anterior\\:\\ 0\\.0030065475734463625\ \(0\)\
\-\ for\\:\\ 0\\.002988148150175062\ \(0\)\
\-\ both\\:\\ 0\\.0029811475282597285\ \(0\)\
\-\ over\\:\\ 0\\.0029721893307922986\ \(0\)\
\-\ metastatic\\:\\ 0\\.002938674048655861\ \(0\)\
\-\ more\\:\\ 0\\.002919639766819899\ \(0\)\
\-\ symptoms\\:\\ 0\\.002909368137838988\ \(0\)\
\-\ acute\\:\\ 0\\.002882348810254775\ \(0\)\
\-\ physical\\:\\ 0\\.0028640782371328393\ \(0\)\
\-\ upper\\:\\ 0\\.0028170498707222927\ \(0\)\
\-\ noted\\:\\ 0\\.002766968836683871\ \(0\)\
\-\ 3\\:\\ 0\\.0027335731239160376\ \(0\)\
\-\ tumor\\:\\ 0\\.002721628827337174\ \(0\)\
\-\ most\\:\\ 0\\.0026951299750383553\ \(0\)\
\-\ other\\:\\ 0\\.002690763044675476\ \(0\)\
\-\ present\\:\\ 0\\.002636623980780985\ \(0\)\
\-\ lower\\:\\ 0\\.0026254946302785007\ \(0\)\
\-\ exam\\:\\ 0\\.0025645272403682215\ \(0\)\
\-\ have\\:\\ 0\\.0025279208720834587\ \(0\)\
\-\ after\\:\\ 0\\.002415302189356834\ \(0\)\
\-\ treatment\\:\\ 0\\.0023628646989083154\ \(0\)\
\-\ has\\:\\ 0\\.002192213074445735\ \(0\)\
\-\ male\\:\\ 0\\.0021109365271686793\ \(0\)\
\-\ that\\:\\ 0\\.002016367115517518\ \(0\)\
\-\ on\\:\\ 0\\.0019778442960804044\ \(0\)\
\-\ be\\:\\ 0\\.001800214102928865\ \(0\)\
\-\ to\\:\\ 0\\.0017502791329630585\ \(0\)\
\-\ there\\:\\ 0\\.0017373163339685638\ \(0\)\
\-\ not\\:\\ 0\\.0016869107537458134\ \(0\)\
\-\ an\\:\\ 0\\.001614296262684057\ \(0\)\
\-\ history\\:\\ 0\\.0016123149422227914\ \(0\)\
\-\ with\\:\\ 0\\.001438575935531431\ \(0\)\
\-\ this\\:\\ 0\\.0013130289799373402\ \(0\)\
\-\ patient\\:\\ 0\\.001170207555896705\ \(0\)\
\-\ \\.\\:\\ 0\\.0008729394122298264\ \(0\)\
